Policy Reforms in Global Rare Disease Regulation
Policy Reforms in Global Rare Disease Regulation How Global Policy Reforms Are Shaping the Future of Rare Disease Regulation The Need for Regulatory Reform in Rare Disease Drug Development Rare diseases, often called orphan conditions, affect over 300 million people globally—yet less than 5% have an approved treatment. Traditional drug development frameworks often fall short…
Read More “Policy Reforms in Global Rare Disease Regulation” »